Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation

Journal of Clinical Investigation

Volumn 110, Issue 6, 2002, Pages 807-814

  Gussoni, Emanuela ^a   Bennett, Richard R ^a   Muskiewicz, Kristina R ^a   Meyerrose, Todd ^b   Nolta, Jan A ^b   Gilgoff, Irene ^c   Stein, James ^b   Chan, Yiu Mo ^d   Lidov, Hart G ^a   Bönnemann, Carsten G ^e   Von Moers, Arpad ^f   Morris, Glenn E ^g   Den Dunnen, Johan T ^h   Chamberlain, Jeffrey S ⁱ   Kunkel, Louis M ^a   Weinberg, Kenneth ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^d WEIS CENTER FOR RESEARCH   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g GLYNDWR UNIVERSITY   (United Kingdom)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DYSTROPHIN; IMMUNOGLOBULIN; STEROID;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; DISEASE COURSE; DONOR; DUCHENNE MUSCULAR DYSTROPHY; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYPOGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; MUSCLE FIBRIL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

EID: 0036736786     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216098     Document Type: Article

References (54)

1. Immunological reconstitution of sex-linked lymphopenic immunological deficiency
2. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
3. Bone marrow transplantation in Fanconi anemia using matched sibling donors
4. Bone marrow transplantation for Fanconi anemia
5. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperrecta
6. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta
7. Bone marrow transplantation for metabolic diseases
8. Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome
9. Marrow stromal cells as stem cells for nonhematopoietic tissues
10. Multilineage potential of adult human mesenchymal stem cells
11. From marrow to brain: Expression of neuronal phenotypes in adult mice
12. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow
13. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
14. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation
15. Neovascularization of ischemic myocardium by human bone-marrow angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
16. Bone marrow cells regenerate infarcted myocardium
17. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell
18. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells
19. Chimerism of the transplanted heart
20. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion
21. Dystrophinopathies
22. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation
23. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin
24. Dystrophin gene transcripts skipping the mdx mutation
25. Massive idiosyncratic exon skipping corrects the non-sense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion
26. Skeletal muscle formation in vertebrates
27. Restoration of normal function in genetically defective myotubes by spontaneous fusion with fibroblasts
28. Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle
29. Muscle regeneration by bone marrow-derived myogenic progenitors
30. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice
31. Dystrophin expression in the mdx mouse restored by stem cell transplantation
32. Dermal fibroblasts participate in the formation of new muscle fibres when implanted into regenerating normal mouse muscle
33. Invited review: Myoblast transfer: A possible therapy for inherited myopathies?
34. Muscle-mediated gene therapy
35. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing
36. Characterization of generic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin
37. An alternative dystrophin transcript specific to the peripheral nerve
38. A method to codetect introduced genes and their products in gene therapy protocols
39. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization
40. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones
41. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells
42. Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections
43. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy
44. Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion
45. Adult rat and human bone marrow stromal cells differentiate into neurons
46. Hepatocytes from non-hepatic adult stem cells
47. Liver from bone marrow in humans
48. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies
49. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene
50. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy
51. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients
52. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy
53. Diagnostic protein expression in human muscle biopsies